Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Quoin Pharmaceuticals Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -651.40%, provide a clear picture of how effectively QNRX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, QNRX competes directly with industry leaders such as PCSA and RDHL. With a market capitalization of $13.77M, it holds a leading position in the sector. When comparing efficiency, QNRX's gross margin of N/A stands against PCSA's N/A and RDHL's 60.60%. Such benchmarking helps identify whether Quoin Pharmaceuticals Ltd is trading at a premium or discount relative to its financial performance.
